drugset / Trial / NCT04433585
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
RandomizedParallel-groupDouble-blindTreatment
Summary
The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).
Timeline
- Start
- 2020-08-19
- Primary completion
- 2023-01-10
- Completion
- 2023-02-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rezpegaldesleukin | Protein / enzyme biologic | — | Subcutaneous |